179 related articles for article (PubMed ID: 34638800)
41. CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
Werner TA; Forster CM; Dizdar L; Verde PE; Raba K; Schott M; Knoefel WT; Krieg A
Br J Cancer; 2017 Dec; 117(12):1837-1845. PubMed ID: 29112684
[TBL] [Abstract][Full Text] [Related]
42. Histopathology of C Cells and Medullary Thyroid Carcinoma.
Schmid KW
Recent Results Cancer Res; 2015; 204():41-60. PubMed ID: 26494383
[TBL] [Abstract][Full Text] [Related]
43. Paraganglioma-like medullary thyroid carcinoma: A case report and literature review.
Hou Y; He X; Chute DJ
Diagn Cytopathol; 2020 Jun; 48(6):559-563. PubMed ID: 32125784
[TBL] [Abstract][Full Text] [Related]
44. Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma.
Werner TA; Tamkan-Ölcek Y; Dizdar L; Riemer JC; Wolf A; Cupisti K; Verde PE; Knoefel WT; Krieg A
Br J Cancer; 2016 Feb; 114(4):427-34. PubMed ID: 26882066
[TBL] [Abstract][Full Text] [Related]
45. C-cell-derived calcitonin-free neuroendocrine carcinoma of the thyroid: the diagnostic importance of CGRP immunoreactivity.
Nakazawa T; Cameselle-Teijeiro J; Vinagre J; Soares P; Rousseau E; Eloy C; Sobrinho-Simões M
Int J Surg Pathol; 2014 Sep; 22(6):530-5. PubMed ID: 24599901
[TBL] [Abstract][Full Text] [Related]
46. Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19.
Deftos LJ; Woloszczuk W; Krisch I; Horvat G; Ulrich W; Neuhold N; Braun O; Reiner A; Srikanta S; Krisch K
Am J Med; 1988 Dec; 85(6):780-4. PubMed ID: 3195602
[TBL] [Abstract][Full Text] [Related]
47. Gangliosides and phospholipids in human thyroids responsive and unresponsive to thyrotropin.
Mariano A; Di Carlo A; Macchia PE; Pisano G; Parmeggiani U; Macchia V
J Endocrinol Invest; 1990 Nov; 13(10):817-23. PubMed ID: 2096158
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors.
Barollo S; Bertazza L; Watutantrige-Fernando S; Censi S; Cavedon E; Galuppini F; Pennelli G; Fassina A; Citton M; Rubin B; Pezzani R; Benna C; Opocher G; Iacobone M; Mian C
PLoS One; 2016; 11(5):e0156044. PubMed ID: 27224648
[TBL] [Abstract][Full Text] [Related]
49. Glycosphingolipids of porcine, bovine, and equine pericardia as potential immune targets in bioprosthetic heart valve grafts.
Barone A; Benktander J; Whiddon C; Jin C; Galli C; Teneberg S; Breimer ME
Xenotransplantation; 2018 Sep; 25(5):e12406. PubMed ID: 29932253
[TBL] [Abstract][Full Text] [Related]
50. ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer.
Bagheri-Yarmand R; Williams MD; Grubbs EG; Gagel RF
J Clin Endocrinol Metab; 2017 Mar; 102(3):933-941. PubMed ID: 27935748
[TBL] [Abstract][Full Text] [Related]
51. Isolation and structural characterization of glycosphingolipids of in vitro propagated human umbilical vein endothelial cells.
Müthing J; Duvar S; Heitmann D; Hanisch FG; Neumann U; Lochnit G; Geyer R; Peter-Katalinic J
Glycobiology; 1999 May; 9(5):459-68. PubMed ID: 10207178
[TBL] [Abstract][Full Text] [Related]
52. Helicobacter pylori SabA binding gangliosides of human stomach.
Benktander J; Barone A; Johansson MM; Teneberg S
Virulence; 2018 Dec; 9(1):738-751. PubMed ID: 29473478
[TBL] [Abstract][Full Text] [Related]
53. Isolation and characterization of the major glycosphingolipids from the liver of the rainbow trout (Oncorhynchus mykiss): identification of an abundant source of 9-O-acetyl GD3.
Ostrander GK; Bozlee M; Fukuda M; Dell A; Thomas-Oates JE; Levery SB; Eaton HL; Hakomori S; Holmes EH
Arch Biochem Biophys; 1991 Feb; 284(2):413-21. PubMed ID: 1989525
[TBL] [Abstract][Full Text] [Related]
54. Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives.
Ceolin L; Duval MADS; Benini AF; Ferreira CV; Maia AL
Endocr Relat Cancer; 2019 Aug; 26(9):R499-R518. PubMed ID: 31252403
[TBL] [Abstract][Full Text] [Related]
55. Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.
Hedayati M; Zarif Yeganeh M; Sheikholeslami S; Afsari F
Crit Rev Clin Lab Sci; 2016 Aug; 53(4):217-27. PubMed ID: 26678667
[TBL] [Abstract][Full Text] [Related]
56. Signification of forkhead box A1 (FOXA1) expression in thyroid cancers.
Missaoui N; Chouaibi S; Limam S; Mhamdi N; Zahmoul T; Hamchi H; Mokni M; Hmissa S
J Egypt Natl Canc Inst; 2019 Dec; 31(1):11. PubMed ID: 32372175
[TBL] [Abstract][Full Text] [Related]
57. PD-1/PD-L1 expressions in medullary thyroid carcinoma: Clinicopathologic and prognostic analysis of Chinese population.
Bi Y; Ren X; Bai X; Meng Y; Luo Y; Cao J; Zhang Y; Liang Z
Eur J Surg Oncol; 2019 Mar; 45(3):353-358. PubMed ID: 30528043
[TBL] [Abstract][Full Text] [Related]
58. Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas.
Katoh R; Miyagi E; Nakamura N; Li X; Suzuki K; Kakudo K; Kobayashi M; Kawaoi A
Hum Pathol; 2000 Mar; 31(3):386-93. PubMed ID: 10746684
[TBL] [Abstract][Full Text] [Related]
59. Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation.
Giardino E; Catalano R; Barbieri AM; Treppiedi D; Mangili F; Spada A; Arosio M; Mantovani G; Peverelli E
Mol Cell Endocrinol; 2019 Sep; 495():110519. PubMed ID: 31352037
[TBL] [Abstract][Full Text] [Related]
60. Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma.
Ferreira LB; Eloy C; Pestana A; Lyra J; Moura M; Prazeres H; Tavares C; Sobrinho-Simões M; Gimba E; Soares P
Eur J Endocrinol; 2016 Apr; 174(4):551-61. PubMed ID: 26811408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]